Application Nr Approved Date Route Status External Links
ANDA091072 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rivastigmine Tartrate Is An Acetylcholinesterase Inhibitor Indicated For Treatment Of: Mild To Moderate Dementia Of The Alzheimer’s Type (1.1) Mild To Moderate Dementia Associated With Parkinson’s Disease (1.2) 1.1 Alzheimer's Disease Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild To Moderate Dementia Of The Alzheimer's Type. 1.2 Parkinson's Disease Dementia Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild To Moderate Dementia Associated With Parkinson’s Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rivastigmine Tartrate RIVASTIGMINE TARTRATE ZINC895301

Comments